alidel

Alidel is a brand name for pimecrolimus, a topical medication used to treat mild to moderate atopic dermatitis, also known as eczema. It belongs to a class of drugs called topical calcineurin inhibitors. Alidel works by suppressing the immune system's activity in the skin, which helps to reduce inflammation, itching, and redness associated with eczema.

Pimecrolimus cream is typically applied to affected areas of the skin twice a day. It is generally used for short-term treatment of eczema flares and for long-term management to prevent recurrence. It is important to follow a doctor's instructions regarding the frequency and duration of use. Alidel is not a steroid and does not cause skin thinning, which can be a side effect of topical corticosteroids.

Common side effects of Alidel can include temporary skin reactions at the application site, such as burning, stinging, itching, or redness. These side effects are usually mild and tend to decrease over time. In rare cases, more serious side effects may occur. The long-term safety of topical calcineurin inhibitors, including Alidel, has been a subject of discussion, with some concerns raised about a potential increased risk of certain cancers. However, regulatory agencies have concluded that the benefits of Alidel outweigh the risks when used as directed. It is crucial to discuss any concerns with a healthcare provider.